Safety and immunogenicity of AS03(B) adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

Objectives To compare the safety, reactogenicity, and immunogenicity of an adjuvanted split virion H1N1 vaccine and a non-adjuvanted whole virion vaccine used in the pandemic immunisation programme in the United Kingdom. Design Open label, randomised, parallel group, phase II study. Setting Five UK...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Waddington, Claire S, Walker, W T, Oeser, C, Reiner, A, John, T, Wilkins, S, Casey, M, Eccleston, P E, Allen, R J, Okike, I, Ladhani, S, Sheasby, E, Hoschler, K, Andrews, N, Waight, P, Collinson, A C, Heath, P T, Finn, A, Faust, S N, Snape, M D, Miller, E, Pollard, A J
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group Ltd. 2010
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2877808/
https://ncbi.nlm.nih.gov/pubmed/20508026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.c2649
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados